Can Microdosing GLP-1s Like Wegovy, Zepbound Help You Lose Weight?

• Current analysis suggests that folks should still shed extra pounds whereas staying on the bottom beginning doses of GLP-1 drugs, resembling Wegovy or Zepbound, for longer durations.
• After one 12 months, folks taking sustained low dose tirzepatide misplaced about 5.5% of their physique weight, whereas these taking sustained low dose semaglutide misplaced about 2.2%.
• Decrease doses had been related to extra modest weight reduction than greater doses, however sustained low dose semaglutide was additionally related to decrease charges of some negative effects.

Individuals should still have the ability to expertise weight reduction by staying on decrease beginning doses of GLP-1 drugs, resembling Wegovy or Zepbound, for longer, in line with analysis revealed in Biology Methods & Protocols on August 31.

Staying on decrease doses of GLP-1 drugs for longer could overlap with a apply generally known as “microdosing,” which has develop into a development amongst celebrities and on social media.

Nonetheless, the research didn’t set up that individuals had been deliberately microdosing, and utilizing these drugs outdoors their authorised dosing schedules shouldn’t be FDA- or manufacturer-approved.

The research included digital well being information from 814 people who met the factors for sustained low dose semaglutide (Ozempic, Wegovy), outlined as not less than three 0.25 mg doses spanning not less than six months. It additionally included 1,016 people who met the factors for sustained low dose tirzepatide (Mounjaro, Zepbound), outlined as 2.5 mg doses spanning not less than six months.

They discovered that these taking sustained low dose tirzepatide for one 12 months noticed round a 5.5% weight reduction, whereas these taking sustained low dose semaglutide for a similar interval noticed round a 2.2% weight reduction.

The researchers additionally in contrast weight reduction trajectories between these taking low dose and excessive dose semaglutide. After matching individuals primarily based on age, intercourse, BMI, and kind 2 diabetes standing, they discovered that these on low dose semaglutide skilled 1.7% weight reduction whereas these on excessive dose semaglutide had about 12% weight reduction.

“These findings introduce an vital remedy paradigm towards rising the notice round ‘microdosing’ for sufferers whose aim is cardiometabolic well being with lesser negative effects than typical dose escalation of those medicines and an related modest sustained weight reduction within the 2-7% vary from baseline,” Venky Soundararajan, PhD, co-founder, chief scientific officer for nference, and co-author of the research, informed Healthline.

Mir Ali, MD, medical director of MemorialCare Surgical Weight Loss Middle at Orange Coast Medical Middle in Fountain Valley, CA, who wasn’t concerned within the research, stated it isn’t stunning to see that folks taking GLP-1 drugs can shed extra pounds even on the lowest dose.

“I’ve seen this in my very own apply. Though these starter doses are typically meant to assist sufferers alter to the remedy, some folks could expertise significant weight reduction even at these decrease doses,” he added.

Soundararajan famous that weight reductions remained evident by way of the 15-month follow-up. This means that the initiation dose could probably function a sustained upkeep technique over many months, moderately than merely a quick stepping stone to the next dose, significantly for a affected person who has already achieved the load loss and cardiometabolic profit they’re searching for.

Nonetheless, Ali cautioned, “In my expertise, many sufferers ultimately attain a degree the place they cease dropping pounds on the bottom dose, though particular person responses can fluctuate significantly. Some sufferers could obtain passable outcomes on a low dose, however most will want some extent of dose escalation to proceed dropping pounds and attain their targets.”

You will need to needless to say whereas some folks expertise fewer negative effects, microdosing could not scale back the negative effects of GLP-1 drugs for everybody.

• nausea or vomiting
• response on the injection web site
• diarrhea
• constipation

Soundararajan informed Healthline that low dose tirzepatide (Zepbound, Mounjaro) was related to modestly extra weight reduction, whereas the general adverse-event sample (negative effects) considerably favored low dose semaglutide (Wegovy), which can be significantly related for people prioritizing cardiometabolic well being and tolerability over maximal weight discount.

“In contrast with sufferers escalating to standard greater doses, sustained lowest-dose semaglutide was related to decrease 24-month charges of constipation (23.3% vs 36.3%), nausea (39.7% vs 50.1%), and low blood strain (1.7% vs 5.4%),” he stated.

“This means that precision weight problems care could more and more contain asking not solely, ‘How a lot weight can this drug assist somebody lose?’ but in addition, ‘What’s the lowest dose that achieves this affected person’s cardiometabolic targets with one of the best tolerability?’”

Ali additionally famous that these findings reinforce that GLP-1 drugs may be efficient for weight reduction even at their lowest doses.

“Nonetheless, the quantity of weight reduction at these doses tends to be extra modest than what’s seen with greater upkeep doses. For many individuals, steadily rising the dose could also be essential to attain larger or continued weight reduction, however the applicable dose finally is dependent upon the person’s response, remedy targets, and skill to tolerate the remedy,” he added.